A novel 11-residual peptaibol-derived carrier peptide for in vitro oligodeoxynucleotide delivery into cell

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 10, 2004, Pages 2563-2566

  Wada, Shun Ich ^a   Tanaka, Reiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Antisense; Carrier peptide; Oligodeoxynucleotide delivery; Peptaibol

Indexed keywords

ACETYL ALPHA AMINOISOBUTYRIC ACID ASPARAGINYLISOLEUCYLISOLEUCYL ALPHA AMINOISOBUTYRIC ACID PROLYLLEUCYLLEUCYL ALPHA AMINOBUTYRIC ACID PROLYLISOLEUCYLLYSYLLYSYLLYSYLLYSYLLYSYLLYSYLLYSYLLYSYLLYSYLLYSINE HYDROXIDE; AMINO ACID; ANTISENSE OLIGODEOXYNUCLEOTIDE; CARRIER PROTEIN; DRUG CARRIER; LYSINE; PEPTAIBOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL STRAIN 3T3; CONJUGATION; CYTOPLASM; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; ELECTRICITY; EMBRYO; ENDOCYTOSIS; ENERGY; FUNGUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; SOLID; THERMODYNAMICS; TRICHODERMA VIRIDE;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; DRUG CARRIERS; FLUORESCENT DYES; MICE; MICROSCOPY, FLUORESCENCE; NIH 3T3 CELLS; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDES; TRICHODERMA;

FUNGI; TRICHODERMA; TRICHODERMA VIRIDE;

EID: 1942534518     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.02.074     Document Type: Article

References (14)

1. For review, see: Helene C., Toulme J.-J. Biochim. Biophys. Acta. 1049:1990;99.
2. For review, see: Chaumont Ch.G., Seksek O., Grzybowska J., Borowski E., Bolard J. Pharmacol. Ther. 87:2000;255.
3. Allinquant B., Hantraye P., Mailleux P., Moya K., Bouillot C., Prochiantz A. J. Cell Biol. 128:1995;919.
4. Spiller D.G., Tidd D.M. Antisense Res. Dev. 5:1995;13.
5. Blanc I., Bueno Da Costa H.-H., Bolard J., Saint-Pierre Chazalet M. Biochim. Biophys. Acta. 1464:2000;299.
6. For review, see: Sansom M.S.P. Q. Rev. Biophys. 26:1993;365.
7. Wada S., Iida A., Asami K., Fujita T. Bioorg. Med. Chem. Lett. 6:1996;2275.
8. Dokka S., Toledo-Velasquez D., Shi X., Wang L., Rojanasakul Y. Pharm. Res. 14:1997;1759.
9. Niidome T., Ohmori N., Ichinose A., Wada A., Mihara H., Hirayama T., Aoyagi H. J. Biol. Chem. 272:1997;15307.
10. Wenschuh H., Beyermann M., Krause E., Brudel M., Winter R., Schumann M., Carpino L.A., Bienert M. J. Org. Chem. 59:1994;3275.
11. ′-diethyl-9-methyl- thiacarbocyanine bromide; 50 μg/mL in 50% formamide solution) for 12 h, and destained in water for 3 h.
12. 2. All studies were performed using asynchronous log-phase cultures. Exponentially growing cells were dissociated with trypsin-ethylenediaminetetraacetic acid (EDTA), plated at 50% confluence on glass microscopes slides (Matsunami Glass Ind., Ltd.) and cultured overnight. The culture medium was discarded and the cells were washed three times with DMEM. The cell monolayers were incubated at 37°C with the complex between the carrier peptide and the ODN for 2 h. Subsequently, the cells were rinsed three times with DMEM at room temperature and fixed with paraformaldehyde [3% (w/v) in phosphate-buffered saline (PBS)] for 10 min at room temperature. For experiments at 4°C, the protocol was the same except that all incubations were performed at 4°C until the end of the fixation procedure. Fixed cell monolayers were then washed three times with PBS. The fluorescence distribution was analyzed on a Carl Zeiss LSM510 confocal microscope equipped with a Kr/Ar laser. We also examined with fixed and unfixed cells and the identical intracellular localization of ODN was observed.
13. Lemaitre M., Bayard B., Lebleu B. Proc. Natl. Acad. Sci. U.S.A. 84:1987;648.
14. Alahari S.K., Fischer M.H., Dean N.M., Viliet P., Juliano R.L. J. Pharmacol. Exp. Ther. 286:1998;419.